Aurora Cannabis Inc (ACB) reports significant revenue increases and maintains a robust cash position, despite challenges in ...

Q1 2026 Earnings Call Transcript August 6, 2025 Aurora Cannabis Inc. misses on earnings expectations. Reported EPS is $-0.19 ...

Despite reporting better-than-expected revenue for Q1 fiscal 2026, Aurora Cannabis (NASDAQ:ACB) traded ~9% lower after the ...

ACB's global medical cannabis momentum stays strong, but near-term regulatory headwinds might have limited Q1 revenue upside.

Aurora Cannabis Inc. shares T.ACB are trading down $0.37 at $5.97.

Aurora said it anticipates revenue will increase year over year in the second fiscal quarter, supported by between 8% and 12% growth in its global medical cannabis segment. Plant propagation revenue ...

Poll: Marijuana consumers expect federal legalization by 2028; Study: Legal dispensaries tied to reduced opioid deaths; Ohio legal sales anniversary Subscribe to receive Marijuana Moment’s newsletter ...

To say Aurora Cannabis (NASDAQ: ACB) has faced some challenges over the years would be a huge understatement. The once-leading cannabis producer in the Canadian marijuana industry is now a shell ...

Aurora Cannabis Inc. closed 37.78% short of its 52-week high of $7.20, which the company reached on August 15th.

Should you buy Aurora Cannabis' stock today? Although Aurora is getting closer to adjusted EBITDA profitability, its net loss was still CA$51.9 million in Q1.

Shares of Aurora Cannabis reached a low of $0.60 on March 18, 2020. If you invested $15,000 in the stock back then, you would have owned 25,000 shares of the cannabis company -- until its reverse ...